[go: up one dir, main page]

WO2008152994A1 - Adsorbent for medical use - Google Patents

Adsorbent for medical use Download PDF

Info

Publication number
WO2008152994A1
WO2008152994A1 PCT/JP2008/060514 JP2008060514W WO2008152994A1 WO 2008152994 A1 WO2008152994 A1 WO 2008152994A1 JP 2008060514 W JP2008060514 W JP 2008060514W WO 2008152994 A1 WO2008152994 A1 WO 2008152994A1
Authority
WO
WIPO (PCT)
Prior art keywords
medical use
adsorbent
less
high adsorption
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/060514
Other languages
French (fr)
Japanese (ja)
Inventor
Takao Mizunoya
Mitsuhiro Saitoh
Toshio Shimizu
Isao Hamasaki
Motoya Mouri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TEIKOKUMEDIX Co Ltd
Original Assignee
TEIKOKUMEDIX Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TEIKOKUMEDIX Co Ltd filed Critical TEIKOKUMEDIX Co Ltd
Publication of WO2008152994A1 publication Critical patent/WO2008152994A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)
  • External Artificial Organs (AREA)

Abstract

It is intended to provide a spherical adsorbent carbon for medical use having high adsorption ability for a toxic substance and also high adsorption rate. The object was achieved by an adsorbent for medical use which is made of a granular phenol resin as a raw material and contains activated carbon in which the total amount of acidic groups is 0.16 meq/g or less, a weight loss rate when it is heated from 100˚C to 900˚C in a nitrogen atmosphere is 2% or less, the volume of pores with a diameter of 0.0075 to 15 μm is 0.1 to 1.0 mL/g, a BET specific surface area is 800 to 2000 m2/g, and an average particle size is 0.1 to 1.5 mm.
PCT/JP2008/060514 2007-06-11 2008-06-09 Adsorbent for medical use Ceased WO2008152994A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007153556A JP5144965B2 (en) 2007-06-11 2007-06-11 Medical adsorbent
JP2007-153556 2007-06-11

Publications (1)

Publication Number Publication Date
WO2008152994A1 true WO2008152994A1 (en) 2008-12-18

Family

ID=40129599

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060514 Ceased WO2008152994A1 (en) 2007-06-11 2008-06-09 Adsorbent for medical use

Country Status (3)

Country Link
JP (1) JP5144965B2 (en)
TW (1) TWI404539B (en)
WO (1) WO2008152994A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014129614A1 (en) * 2013-02-22 2014-08-28 株式会社クレハ Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
EP2601955A4 (en) * 2010-08-02 2015-02-18 Asahi Organic Chem Ind Adsorbent for oral administration, method for producing same, and drug using same
US9877987B2 (en) 2013-02-22 2018-01-30 Kureha Corporation Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
WO2021186579A1 (en) * 2020-03-17 2021-09-23 株式会社大木工藝 Orally ingestible adsorbent and method for producing same

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5352378B2 (en) * 2009-08-10 2013-11-27 マイラン製薬株式会社 Adsorbent for oral administration with excellent adsorption characteristics
JP5376592B2 (en) * 2009-10-15 2013-12-25 産協企業有限股▲ふん▼公司 Spherical activated carbon and manufacturing method thereof
JP5466483B2 (en) * 2009-10-15 2014-04-09 産協企業有限股▲ふん▼公司 Spherical activated carbon and manufacturing method thereof
JP5765649B2 (en) 2010-03-10 2015-08-19 株式会社ダステック Adsorbed charcoal and adsorbent
JP5984352B2 (en) 2010-10-12 2016-09-06 フタムラ化学株式会社 Method for producing pharmaceutical adsorbent for oral administration
WO2012121202A1 (en) 2011-03-04 2012-09-13 株式会社クレハ Tablet-type composition for oral administration and method for producing same
JP2014024817A (en) * 2012-07-30 2014-02-06 Nippon Kayaku Food Techno Kk Preventive or therapeutic agent for chronic renal failure
JP7008540B2 (en) 2018-03-01 2022-01-25 株式会社クレハ Toxin separator
JP7228498B2 (en) 2018-10-24 2023-02-24 フタムラ化学株式会社 Method for producing phenolic resin
CN113874320B (en) 2019-04-16 2023-12-19 二村化学株式会社 Method for manufacturing activated carbon adsorbent
JP7438897B2 (en) * 2020-08-26 2024-02-27 フタムラ化学株式会社 Tablet type adsorbent for oral administration

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094845A1 (en) * 2004-04-02 2005-10-13 Kureha Corporation Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease
JP2005314415A (en) * 2004-04-02 2005-11-10 Kureha Chem Ind Co Ltd Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094845A1 (en) * 2004-04-02 2005-10-13 Kureha Corporation Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease
JP2005314416A (en) * 2004-04-02 2005-11-10 Kureha Chem Ind Co Ltd Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease
JP2005314415A (en) * 2004-04-02 2005-11-10 Kureha Chem Ind Co Ltd Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2601955A4 (en) * 2010-08-02 2015-02-18 Asahi Organic Chem Ind Adsorbent for oral administration, method for producing same, and drug using same
WO2014129614A1 (en) * 2013-02-22 2014-08-28 株式会社クレハ Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
US9877987B2 (en) 2013-02-22 2018-01-30 Kureha Corporation Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
WO2021186579A1 (en) * 2020-03-17 2021-09-23 株式会社大木工藝 Orally ingestible adsorbent and method for producing same
CN114760991A (en) * 2020-03-17 2022-07-15 株式会社大木工艺 Adsorbent for oral intake and process for producing the same

Also Published As

Publication number Publication date
TWI404539B (en) 2013-08-11
TW200911276A (en) 2009-03-16
JP2008303193A (en) 2008-12-18
JP5144965B2 (en) 2013-02-13

Similar Documents

Publication Publication Date Title
WO2008152994A1 (en) Adsorbent for medical use
CA2504517A1 (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
CN104671738B (en) A kind of shale diatom ooze wall material and preparation method thereof
RU2007137631A (en) HIGH-EFFICIENCY ADSORBENTS BASED ON ACTIVATED CARBON WITH HIGH MICROPOROSITY
WO2009060143A3 (en) Crystallised material with hierarchised porosity and containing silicon
KR20040088532A (en) Multi-functional protective materials and methods for use
EP2138230A3 (en) Free Radical Post-Crosslinked Adsorbent and Method of Preparation
ZA200908593B (en) Spherical agglomerates based on zeolite(s), process for the production thereof and use thereof in adsorption processes or in catalysis
WO2009020334A3 (en) Porous polymer particles immobilized with charged molecules and method for preparing the same
JP2011518337A5 (en)
WO2010054715A3 (en) Adsorptive structures and the use thereof
WO2011015429A3 (en) Antimicrobial material for water sterilization comprising a polyamide carrier and elemental silver nanoparticles
MY177923A (en) Medical adsorbent and method for producing same
EP2138229A3 (en) Friedel-Crafts Post-Crosslinked Adsorbent and Method of Preparation
UA102535C2 (en) Electrode for capacitative deionization
HK1242919A1 (en) Polymeric hybrid particle containing nano particles and uses
WO2008094897A3 (en) Catheters and medical balloons
Acevedo et al. Efficiency study of silver nanoparticles (AgNPs) supported on granular activated carbon against Escherichia coli
WO2010037967A3 (en) Method for treating a gas to reduce the carbon dioxide content thereof
IN2012DN03184A (en)
WO2009132912A3 (en) Surface-modified superparamagnetic oxidic particles
Solomon The emergence of nanotechnology and its applications
WO2008055855A3 (en) Photonic crystals which are produced from uncharged polymer particles
WO2012125642A3 (en) Filled porous membrane
CA2504514A1 (en) Adsorbent for oral administration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08765315

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08765315

Country of ref document: EP

Kind code of ref document: A1